Chai Discovery
PrivateLast Round
Series C
Jul 14, 2026
Est. Valuation
$3.8B
Total Funding Raised
$630M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Chai Discovery is a biotechnology company that offers a generative AI platform for designing and reprogramming biochemical molecules to accelerate drug discovery.
Sector
AI, Data & Cloud Infrastructure
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Revenue Share, Services & Consulting
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chai Discovery Comparables
Compare Chai Discovery with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioMap | 84% | |
| Profluent Bio | 82% | |
| Insilico Medicine | 82% |
Chai Discovery Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 14, 2026 | ||||
| Series B | Dec 15, 2025 | ||||
| Series A | Aug 6, 2025 | ||||
| Seed | Sep 9, 2024 |
Chai Discovery Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bain Capital Ventures | Series C |
| DST Global | Series A |
| Neo | Series B, Seed, Series A |
| SV Angel | Series B, Series A |
| Avra | Series C |
| Oak HC/FT | Series C, Series B |
| Conviction | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Grew 17% QoQ, from 36 to 42 employees.
- Aug 20, 2026
Monthly visitors grew 69% MoM, reaching 33.4K.
Recent news
Latest coverage and updates
- partners_withAug 21, 2026
Chai Discovery Inc. partnered with Bristol-Myers Squibb Co on Aug 20th '26.
- receives_financingJul 15, 2026
Chai Discovery Inc. received financing of $400M in Series C on Jul 14th '26.
- partners_withJul 14, 2026
Chai Discovery Inc. partnered with Novartis AG on Jul 13th '26.
- is_developingJul 14, 2026
Chai Discovery Inc. is developing AI models that predict and reprogram molecular interactions.
- is_developingJun 23, 2026
Chaidiscovery is developing tools to accelerate therapeutic design workflows on Jun 23rd '26.
Chai Discovery Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Chai Discovery's valuation, stock price, and market status.
Is Chai Discovery a public or private company?
Chai Discovery is a private company.
What is the current stock price of Chai Discovery?
Chai Discovery is a private company with no public stock price. No recent secondary market data is available.
How much is Chai Discovery worth (valuation)?
Chai Discovery's valuation is estimated at $1.3B based on funding round data.
Can I buy Chai Discovery stock?
Chai Discovery shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Chai Discovery's last funding round?
Chai Discovery's most recent funding round was Series B on December 15, 2025.
Who are the main investors in Chai Discovery?
Key investors in Chai Discovery include Oak HC/FT, Thrive Capital, General Catalyst, Dimension, Menlo Ventures.
Will Chai Discovery IPO soon?
No public IPO plans have been announced for Chai Discovery.
How can I track Chai Discovery secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Chai Discovery's secondary market activity and sign up for updates.